leadf
logo-loader

Newomics Inc.

Receive alerts
Market:
Unlisted
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Newomics Inc. is dedicated to creating and commercializing innovative (New) and integrative (Omics) platforms and solutions for precision medicine. Our initial M3 emitter product line enables unprecedented gains in sensitivity, throughput, and robustness for liquid chromatography – mass spectrometry (LC-MS). The multinozzle emitter array (MEA) technology, invented at the Lawrence Berkeley National Laboratory, won the 2012 R&D 100 award.